Request Trial
19 December 2024NewsAmericasRachel Elsby Partner Akin, Renee Fuller Senior Corporate Counsel Innovation Law Bristol Myers Squibb, Alexis Simpson Senior Counsel II Patent Strategy & Analytics Gilead Sciences, Nathaniel Leachman Senior Corporate Counsel Pfizer

WATCH: AI and machine learning in drug discovery - patenting AI-generated inventions

Speakers from Akin, Bristol Myers Squibb, Gilead Sciences, and Pfizer discuss how AI accelerates drug discovery, from target identification to predictive modelling, reducing costs and enhancing therapeutic outcomes.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Appeals court eases Teva’s headache with reversal
17 April 2026   A ruling that invalidated three of Teva's headache treatment patents has been thrown out, sending a long-running case back to the lower court.
Americas
Cancer drug researcher hit with suit over mutation-targeting tools
16 April 2026   The Cambridge biotech is accused of infringing six patents covering technologies used to target drug-resistant cancer mutations.
Americas
Court narrows Mylan’s Copaxone suit but key claims survive
14 April 2026   A US district court has allowed key elements of the generic drugmaker’s case against a rival to move forward, while drawing clear limits on how far the complaint can reach.


Editor's picks

Closing the women's health gap offers ‘benefits for all’
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026

Editor's picks

Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Americas
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
1 April 2026
Europe
WIPR debuts Global In-House Elite 2026
26 March 2026
Biotechnology
mRNA litigation: Who’s winning, who’s filing, and what’s next
25 March 2026
Americas
Masimo convinces judge that Apple took secrets—but it’s not enough
19 March 2026
Americas
Abbott IP chief: ‘Firms without AI policies scare me’
5 March 2026

More features

Appeals court eases Teva’s headache with reversal
Simmons & Simmons makes senior Asia trademark hire
Baker McKenzie strengthens IP bench with new German lead
Cancer drug researcher hit with suit over mutation-targeting tools
Novo Nordisk and OpenAI strike AI deal to boost drug discovery
Court narrows Mylan’s Copaxone suit but key claims survive
IP finance gap risks startup exodus, EUIPO warns
Oracle retaliates with lawsuit to laid-off staff member’s ‘demands’